Case number IPR2018-00186
Pfizer, Inc. v. Biogen Inc. > Documents
| Date Field | Doc. No. | Party | Description |
|---|---|---|---|
| Dec 1, 2017 | 1 | Petitioner 's Power of Attorney Download | |
| Dec 1, 2017 | 2 | PETITION FOR INTER PARTES REVIEW (NHL '821) Download | |
| Dec 18, 2017 | 3 | Notice of Accord Filing Date Download | |
| Dec 22, 2017 | 4 | Power of Attorney Download | |
| Dec 22, 2017 | 5 | Mandatory Notice Download | |
| Jan 31, 2018 | 6 | Petitioner's Updated Mandatory Notice Download | |
| Feb 2, 2018 | 7 | Petitioner's Unopposed Motion For PHV Admission Of Charles B. Klein and Eimeric Reig-Plessis Download | |
| Feb 2, 2018 | 8 | PETITIONER'S UPDATED EXHIBIT LIST (AS OF FEBRUARY 2, 2018) Download | |
| Mar 19, 2018 | 9 | Patent Owner Preliminary Response Download | |
| Apr 4, 2018 | 10 | DECISION Granting Motion for Pro Hac Vice Recognition of Mr. Charles B. Klein and Mr. Eimeric Reig-Plessis Download | |
| Apr 4, 2018 | 11 | DECISION Conduct of the Proceeding Download | |
| Apr 11, 2018 | 12 | Petitioner¿¿¿s Authorized Reply To Patent Owner Preliminary Response Download | |
| Apr 18, 2018 | 13 | Patent Owners Sur-Reply to Petitioners Reply Download | |
| Apr 18, 2018 | 14 | Patent Owners Mandatory Notice Updating Related Matters Download | |
| Jun 14, 2018 | 15 | Decision Institution of Inter Partes Review Download | |
| Jun 18, 2018 | 16 | Scheduling Order Download | |
| Jun 28, 2018 | 17 | Patent Owner's Objections to Evidence Under 37 C.F.R. 42.64 Download | |
| Jun 28, 2018 | 18 | Petitioner¿¿¿s Objections To Exhibits Download | |
| Jul 13, 2018 | 19 | Petitioner's Service of Supplemental Evidence Download | |
| Jul 13, 2018 | 20 | Petitioner's Updated Exhibits List (as of July 13, 2018 Download | |
| Jul 20, 2018 | 21 | Petitioner's Unopposed Motion To Substitute The Declaration Of Dr. Ozer Download | |
| Aug 1, 2018 | 22 | Petitioner's Unopposed Motion For PHV Admission Of Amit H. Thakore And Leon Miniovich Download | |
| Aug 1, 2018 | 23 | Petitioner's Updated Exhibit List (As Of August 1, 2018) Download | |
| Aug 1, 2018 | 24 | Petitioner's Updated Power Of Attorney Appointing Additional Counsel Download | |
| Aug 1, 2018 | 25 | Petitioner's Updated Mandatory Notice Download | |
| Aug 10, 2018 | 26 | Decision - 37 C.F.R. 42.5 Download | |
| Aug 13, 2018 | 27 | Joint Stipulation to Modify Due Dates 1-5 Download | |
| Aug 14, 2018 | 28 | Order Granting Petitioner's Motion for Pro Hac Vice Recognition of Mr. Amit H. Thakore and Mr. Leon Miniovich Download | |
| Aug 14, 2018 | 29 | Petitioner's Updated Exhibit List (As Of August 14, 2018) Download | |
| Aug 21, 2018 | 30 | Patent Owner's Objections to Evidence Download | |
| Aug 27, 2018 | 31 | Notice of Deposition of Robert J. Soiffer Download | |
| Oct 8, 2018 | 32 | Patent Owner's Response Download | |
| Oct 31, 2018 | 33 | Joint Motion to Terminate Proceeding Download | |
| Nov 8, 2018 | 34 | Judgment Termination of the Proceeding Download | |
| Dec 1, 2017 | 1001 | Ex. 1001 - Antonio J. Grillo-Lopez, U.S. Patent No. 9,296,821 B2 Download | |
| Dec 1, 2017 | 1002 | Ex. 1002 - Declaration of Howard Ozer, M.D., Ph.D. Download | |
| Dec 1, 2017 | 1003 | Ex. 1003 - Steward et al., "Maintenance Chlorambucil After CVP in the Management of Advanced Stage, Low-Grade Histologic Type Non-Hodgkin's Lymphoma," Cancer, 61(3):441-447 (1998) Download | |
| Dec 1, 2017 | 1004 | Ex. 1004 - Czuczman et al., "IDEC-C2B8 and CHOP Chemoimmunotherapy of Low-Grade Lymphoma," Blood, 86(10 Supp. 1):55a (1995) Download | |
| Dec 1, 2017 | 1005 | Ex. 1005 - Maloney et al., "IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients with Relapsed Low-Grade Non-Hodgkin's Lymphoma," Blood, 90(6):2188-2195 (1997) Download | |
| Dec 1, 2017 | 1006 | Ex. 1006 - Kenneth A. Foon & Richard I. Fisher, "Lymphomas" in Williams Hematology 5th Ed. (Ernest Beutler et al., eds.) 1076-1096 (1995) Download | |
| Dec 1, 2017 | 1007 | Ex. 1007 - Dana et al., "Long-Term Follow-Up of Patients with Low-Grade Malignant Lymphomas Treated with Doxorubicin-Based Chemotherapy or Chemoimmunotherapy," J. Clinical Oncology 11(4):644-651 (1993) Download | |
| Dec 1, 2017 | 1008 | Ex. 1008 - Marcus et al., "CVP Chemotherapy Plus Rituximab Compared with CVP as First-Line Treatment for Advanced Follicular Lymphoma," Blood, 105(4):1417-1423 (2005) Download | |
| Dec 1, 2017 | 1009 | Ex. 1009 - Lauren C. Pinter-Brown and Dennis A. Casciato, "Hodgkin and Non-Hodgkin Lymphoma," in Manual of Clinical Oncology 6th Ed. (Dennis A. Casciato, ed.) 431-470 (2009) Download | |
| Dec 1, 2017 | 1010 | Ex. 1010 - Anderson et al., U.S. Patent No. 5,736,137 Download | |
| Dec 1, 2017 | 1011 | Ex. 1011 - Rituxan (rituximab) labeling (Nov. 1997) ("FDA label") Download | |
| Dec 1, 2017 | 1012 | Ex. 1012 - Physicians' Desk Reference (53rd ed. 1999) (excerpted), "Rituxan (Rituximab)" ("PDR label") Download | |
| Dec 1, 2017 | 1013 | Ex. 1013 - Maloney et al., "IDEC-C2B8: Results of a Phase I Multiple-Dose Trial in Patients with Relapsed Non-Hodgkin's Lymphoma," J. Clinical Oncology, 15(10):3266-3274 (1997) Download | |
| Dec 1, 2017 | 1014 | Ex. 1014 - Arthur T. Skarin & David M. Dorfman, "Non-Hodgkin's Lymphomas: Current Classification and Management," CA Cancer J. Clinicians, 47(6):351-372 (1997) Download | |
| Dec 1, 2017 | 1015 | Ex. 1015 - W. Hiddemann, "Non-Hodgkin's Lymphoma-Current Status of Therapy and Future Perspectives," Eur. J. Cancer, 31A:2141-2145 (1995) Download | |
| Dec 1, 2017 | 1016 | Ex. 1016 - Sriskandan et al., "Aggressive Management of Doxorubicin-Induced Cardiomyopathy Associated with 'Low' Doses of Doxorubicin," Postgraduate Med. J., 70(828):759-761 (1994) Download | |
| Dec 1, 2017 | 1017 | Ex. 1017 - Bishop et al., "A Randomized Trial of High Dose Cyclophosphamide, Vincristine, and Prednisone Plus or Minus Doxorubicin (CVP Versus CAVP) with Long-Term Follow-up in Advanced Non-Hodgkin's Lymphoma," Leukemia, 1(6):508-513 (1987) Download | |
| Dec 1, 2017 | 1018 | Ex. 1018 - McLaughlin et al., "Rituximab Chimeric Anti-CD Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program," J. Clinical Oncology, 16(8):2825-2833 (1998) Download | |
| Dec 1, 2017 | 1019 | Ex. 1019 - Pierre Feugier, "A Review of Rituximab, the First Anti-CD20 Monoclonal Antibody Used in the Treatment of B Non-Hodgkin's Lymphomas," Future Oncology, 11(9):1327-1342 (2015) Download | |
| Dec 1, 2017 | 1020 | Ex. 1020 - Demidem et al., "Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic Drugs," Cancer Biotherapy & Radiopharmaceuticals, 12(3):177-186 (1997) Download | |
| Dec 1, 2017 | 1021 | Ex. 1021 - Declaration of Sylvia D. Hall-Ellis, Ph.D. Download | |
| Dec 1, 2017 | 1022 | Ex. 1022 - Institution of Inter Partes Review, Celltrion, Inc. v. Biogen, Inc., IPR2017-01095 (U.S. Patent No. 9,296,821) Paper 12 (PTAB) Download | |
| Dec 1, 2017 | 1023 | Ex. 1023 - Petition for Inter Partes Review, Celltrion, Inc. v. Biogen, Inc., IPR2017-01095 (U.S. Patent No. 9,296,821) Paper 2 (PTAB) Download | |
| Dec 1, 2017 | 1024 | Ex. 1024 - U.S. Application No. 09/372,202 (dated August 11, 1999) Download | |
| Dec 1, 2017 | 1025 | Ex. 1025 - U.S. Application No. 13/524,896, Non-Final Office Action (dated December 31, 2012) Download | |
| Dec 1, 2017 | 1026 | Ex. 1026 - U.S. Application No. 13/524,896, Amendment and Response (dated March 28, 2013) Download | |
| Dec 1, 2017 | 1027 | Ex. 1027 - U.S. Application No. 13/524,896, Amendment and Response (dated April 25, 2014) Download | |
| Dec 1, 2017 | 1028 | Ex. 1028 - U.S. Application No. 13/524,896, Final Office Rejection (dated September 16, 2014) Download | |
| Dec 1, 2017 | 1029 | Ex. 1029 - U.S. Application No. 13/524,896, Amendment and Response (dated September 18, 2015) Download | |
| Dec 1, 2017 | 1030 | Ex. 1030 - U.S. Application No. 13/524,896, Applicant-Initiated Interview Summary and Notice of Issuance (dated February 26, 2016) Download | |
| Dec 1, 2017 | 1031 | Ex. 1031 - U.S. Provisional Application No. 60/096,180 (filed August 11, 1998) Download | |
| Dec 1, 2017 | 1032 | Ex. 1032 - Michael J. Campbell & John E. Niederhuber, "B-Lymphocyte Responses," Clinical Oncology, Abeloff et al., Eds. (1995), 100-126 Download | |
| Dec 1, 2017 | 1033 | Ex. 1033 - Michael L. Grossbard and Pratik S. Multani, "Clinical Status and Optimal Use of Rituximab for B-Cell Lymphomas," Psychiatric Times, (December 1, 1998) Download | |
| Feb 2, 2018 | 1034 | Ex. 1034 - Declaration Of Charles B. Klein ISO PHV Motion Download | |
| Feb 2, 2018 | 1035 | Ex. 1035 - Declaration Of Eimeric Reig-Plessis ISO PHV Motion Download | |
| Aug 1, 2018 | 1037 | Ex. 1037 Declaration Of Amit H. Thakore ISO Unopposed Motion for PHV Admission Download | |
| Aug 1, 2018 | 1038 | Ex. 1038 Declaration Of Leon Miniovich ISO Unopposed Motion for PHV Admission Download | |
| Aug 14, 2018 | 1039 | Ex. 1039 - Declaration of Robert Soiffer, M.D. Download | |
| Mar 19, 2018 | 2001 | EX2001 - File History of U.S. Patent Application No. 09/372,202 Download | |
| Mar 19, 2018 | 2002 | EX2002 - Carlson Download | |
| Mar 19, 2018 | 2003 | EX2003 - Czuczman Download | |
| Mar 19, 2018 | 2004 | EX2004 - File History for Application No. 11/840,956 Download | |
| Mar 19, 2018 | 2005 | EX2005 - File History for Application No. 13/521,896 Download | |
| Mar 19, 2018 | 2006 | EX2006 - Declaration of Megan Raymond Download | |
| Mar 19, 2018 | 2007 | EX2007 - Deposition Transcript of Izidore Lossos, M.D. Download | |
| Mar 19, 2018 | 2008 | EX2008 - Hagenbeek Download | |
| Mar 19, 2018 | 2009 | EX2009 - Demidem Download | |
| Mar 19, 2018 | 2010 | EX2010 - Maloney Download | |
| Oct 8, 2018 | 2011 | EX2011 - Al-Ismail Download | |
| Oct 8, 2018 | 2012 | EX2012 - Declaration of Peter McLaughlin, M.D. Download | |
| Oct 8, 2018 | 2013 | EX2013 - Horning Download | |
| Oct 8, 2018 | 2014 | EX2014 - Lopez-Guillermo Download | |
| Oct 8, 2018 | 2015 | EX2015 - Czuczman 1999 Download | |
| Oct 8, 2018 | 2016 | EX2016 - Gribben Download | |
| Oct 8, 2018 | 2017 | EX2017 - Rigacci Download | |
| Oct 8, 2018 | 2018 | EX2018 - Czuczman 2004 Download | |
| Oct 8, 2018 | 2019 | EX2019 - Dep. Tr. of Robert J. Soiffer, M.D. Download | |
| Oct 8, 2018 | 2020 | EX2020 - Ezdinli Download | |
| Oct 8, 2018 | 2021 | EX2021 - Han Download | |
| Oct 8, 2018 | 2022 | EX2022 - Declaration of Sayem Osman Download | |
| Oct 8, 2018 | 2023 | EX2023 - Rituxan Prescribing Information Download | |
| Oct 8, 2018 | 2024 | EX2024 - Korsmeyer Download | |
| Oct 8, 2018 | 2025 | EX2025 - Leget Download | |
| Oct 8, 2018 | 2027 | EX2027 - Kimby Download | |
| Oct 8, 2018 | 2028 | EX2028 - Czuczman 1996 Download | |
| Oct 8, 2018 | 2029 | EX2029 - Hoppe Download | |
| Oct 8, 2018 | 2030 | EX2030 - Raphael Download | |
| Oct 8, 2018 | 2031 | EX2031 - McNeil Download | |
| Oct 8, 2018 | 2032 | EX2032 - Fisher Download | |
| Oct 8, 2018 | 2033 | EX2033 - Rosenberg Download | |
| Oct 8, 2018 | 2034 | EX2034 - Peterson Download | |
| Oct 8, 2018 | 2035 | EX2035 - McLaughlin 1987 Download | |
| Oct 8, 2018 | 2036 | EX2036 - McLaughlin 1992 Download | |
| Oct 8, 2018 | 2037 | EX2037 - Smalley Download | |
| Oct 8, 2018 | 2038 | EX2038 - Maccio Download | |
| Oct 8, 2018 | 2039 | EX2039 - Weijl Download | |
| Oct 8, 2018 | 2040 | EX2040 - McLaughlin 1998 Download | |
| Oct 8, 2018 | 2042 | EX2042 - Solal-Celigny Download | |
| Oct 8, 2018 | 2043 | EX2043 - Young Download | |
| Oct 8, 2018 | 2101 | EX2101 - Dep. Tr. of Robert J. Soiffer, M.D. (IPR2017-01168) Download | |
| Nov 8, 2018 | 3001 | Email Download |
